RevMed
Home/Specialty/Other/System, Test, Tumor Marker, For Detection Of Bladder Cancer

System, Test, Tumor Marker, For Detection Of Bladder Cancer

9 Results
Results Per Page
  • 50
  • 100
  • 250
Catalog #
Qty
Starting At
Name
Company Name
Description
0
-
SOUTHERN IMPLANTS (PTY) LTD
Titanium Cylinder for Ø4.0 Ex Hex Passive Abutment, Non-Engaging
0
-
Contour Healer
CONTOUR HEALER, LLC
Temporary analog for Nobel Replace 3.5mm
0
-
Contour Healer
CONTOUR HEALER, LLC
Temporary analog for Hiossen Standard Connection Compatible device
0
-
Contour Healer
CONTOUR HEALER, LLC
Temporary analog for Nobel ™ Conical Connection Compatible 4.3/5.0 mm devices
0
-
Alere NMP22 BladderChek Test
Alere Scarborough, Inc.
The Alere NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.
0
-
Alere NMP22® Urine Collection Kit
Alere Scarborough, Inc.
The Alere NMP22® Urine Collection Kit is intended for the collection, stabilization, and transport of human urine which will be tested using the Alere NMP22® (ELISA)Test Kit .
0
-
Alere NMP22 BladderChek Test
Alere Scarborough, Inc.
The Alere NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.
0
-
Alere NMP22 Test
Alere Scarborough, Inc.
For the in vitro quantitative measurement of the Nuclear Matrix Protein NMP22 in stabilized urine (ELISA).
0
-
NMP22 BladderChek Test
Alere Scarborough, Inc.
NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.